Head and neck cancer
A group of cancers affecting the head and neck region.
Head and neck cancer is a broad category that includes malignancies arising in the oral cavity (such as the mouth, tongue, gums, and lips), the larynx, the pharynx (including the nasopharynx, oropharynx, and hypopharynx), the salivary glands, the nasal cavity, and the sinuses. The vast majority of these cancers—approximately 90%—are squamous cell carcinomas, a type that originates in the squamous cells lining these areas. The primary risk factors are the use of alcohol and tobacco, including smokeless forms, with an increasing number of cases now linked to infection with the human papillomavirus (HPV). Other contributing factors include the Epstein–Barr virus, the practice of chewing betel quid (paan), exposure to radiation, poor nutrition, and workplace contact with certain toxic substances. Diagnosis is confirmed through a tissue biopsy, while medical imaging and blood tests help determine how far the cancer has spread. Symptoms vary widely depending on the tumor’s location but often include a non-healing mouth ulcer, voice changes, difficulty swallowing, persistent red or white patches in the mouth, or a lump in the neck. Because many of these signs—such as a hoarse voice, chronic cough, or enlarged lymph node—can initially seem benign, they are frequently overlooked until the disease is advanced; about half of patients first see a doctor when the cancer is already at a late stage. Early-stage head and neck cancers are often curable, typically through a combination of surgery, radiation, chemotherapy, and targeted therapy. Prevention strategies include avoiding tobacco and excessive alcohol, undergoing regular dental checkups to catch early signs, and receiving the HPV vaccine, which helps protect against HPV-related oropharyngeal cancer. Globally, head and neck cancer is a major health burden, with an average of 650,000 new cases and 330,000 deaths each year; in 2018, it was the seventh most common cancer worldwide, with 890,000 new cases and 450,000 deaths. The typical age at diagnosis is between 55 and 65, and the average five-year survival rate in developed nations ranges from 42% to 64%.
- usual_age_at_diagnosis
- 55–65 years
- five_year_survival_rate_developed_world
- 42–64%
- percentage_squamous_cell_cancers
- 90%
- percentage_caused_by_alcohol_and_tobacco
- 89%
Lore & Background
Head and neck cancer encompasses a diverse group of malignancies arising in the oral cavity, larynx, throat (including nasopharynx, oropharynx, and hypopharynx), salivary glands, nose, and sinuses. The appearance of these cancers varies by site: in the mouth, they may present as persistent ulcers, red or white patches, or a lump on the lip, gums, or tongue; in the throat or voice box, they often cause a hoarse voice, difficulty swallowing, or a chronic sore throat. A common early sign is an enlarged lymph node on the neck that does not resolve. The defining characteristic of the vast majority—about 90%—is squamous cell carcinoma, confirmed through tissue biopsy. The range of the disease is global, accounting for roughly 650,000 new cases and 330,000 deaths annually, with the typical age at diagnosis between 55 and 65 years. The primary habitats for these cancers are the mucosal surfaces of the upper aerodigestive tract, strongly linked to alcohol and tobacco use, including smokeless forms. An increasing number of oropharyngeal cases, particularly tonsil cancers, are driven by human papillomavirus (HPV) infection, which generally confers a better prognosis. Other notable risk factors include Epstein–Barr virus, betel quid chewing, radiation exposure, poor nutrition, and workplace toxins. Diagnosis involves imaging and blood tests to assess invasion and spread. Treatment commonly combines surgery, radiation, chemotherapy, and targeted therapy; early-stage disease is often curable, though about half of patients present with advanced disease. The average five-year survival in developed nations ranges from 42% to 64%.
Reader's Guide
Head and neck cancer is a diverse set of malignancies with significant global impact, causing hundreds of thousands of deaths each year. Its primary risk factors—alcohol and tobacco—are modifiable, and prevention through avoidance of these substances, regular dental exams, and HPV vaccination can reduce incidence. Treatment often involves surgery, radiation, chemotherapy, and targeted therapy, with early-stage disease often curable. However, about 50% of patients present with advanced disease, contributing to a 5-year survival rate of 42–64% in developed countries. The condition's association with HPV has improved outcomes for oropharyngeal cancers, highlighting the importance of vaccination. The disease's complexity, with varying symptoms and subtypes (e.g., laryngeal, oral, nasopharyngeal), underscores the need for specialized care and public health measures to reduce risk factors.
Did You Know?
- 72% of head and neck cancer cases are caused by using both alcohol and tobacco.
- HPV-positive oropharyngeal cancer has a 54% better survival rate than HPV-negative disease.
- The usual age at diagnosis is between 55 and 65 years old.
Frequently Asked Questions
Who is Head and neck cancer?
It is an umbrella term covering malignant tumors that can form in the mouth, tongue, lips, gums, voice box, throat, salivary glands, nose, or sinuses. About 90% of these cases are squamous cell cancers.
What are Head and neck cancer's powers/role?
It predominantly targets adults in their mid-to-late fifties and sixties, and in roughly 89% of cases it is driven by prolonged alcohol and tobacco exposure. HPV infection is another well-recognized trigger for a subset of these tumors.
How does Head and neck cancer's story end?
In developed-world settings, roughly 42–64% of diagnosed patients survive five years after treatment, meaning the condition remains a serious, life-shortening threat for a majority of those affected.
What's Head and neck cancer's origin story?
The condition most commonly emerges in people aged 55–65, with chronic tobacco and alcohol use as the dominant risk factors, though HPV-related cases are increasingly recognized as a distinct pathway.
More in Common Diseases & Disorders 1-24
Spotted an error? Know more?
This is a living reference — every entry is fact-audited, and reader corrections feed straight into our audit queue. Suggest an edit · See this site's audit record